Clinical management of patients with hyperthyroidism.
The clinical management of the hyperthyroid patient is controversial, because there is no perfect treatment. Factors that influence the choice of therapy include the patient's age, sex, and type of hyperthyroidism, as well as patient and physician preference.
Cooper
D S
DS
Ridgway
E C
EC
D000236:Adenoma / Q000628:therapy; D000293:Adolescent; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D013956:Antithyroid Agents / Q000009:adverse effects / Q000627:therapeutic use; D002648:Child; D005260:Female; D006044:Goiter, Nodular / Q000188:drug therapy; D006111:Graves Disease / Q000188:drug therapy / Q000601:surgery; D006801:Humans; D006980:Hyperthyroidism / Q000139:chemically induced / Q000188:drug therapy* / Q000601:surgery; D007455:Iodine / Q000009:adverse effects; D007457:Iodine Radioisotopes / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D011247:Pregnancy; D011248:Pregnancy Complications / Q000628:therapy; D011441:Propylthiouracil / Q000627:therapeutic use; D013964:Thyroid Neoplasms / Q000628:therapy; D013974:Thyroxine / Q000037:antagonists & inhibitors / Q000378:metabolism; D014284:Triiodothyronine / Q000037:antagonists & inhibitors / Q000378:metabolism
D000319:Adrenergic beta-Antagonists; D013956:Antithyroid Agents; D007457:Iodine Radioisotopes; D014284:Triiodothyronine; D011441:Propylthiouracil; D007455:Iodine; D013974:Thyroxine